KRAS – BRAF StripAssay®
Dual KRAS and BRAF Mutation Detection
The KRAS–BRAF StripAssay® is a combination assay detecting 10 mutations in codons 12 and 13 of the KRAS gene as well as the V600E mutation in the BRAF gene, offering a highly cost-effective option for dual mutation profiling in a single test.
Key Features
Dual Mutation Panel
Detects 10 KRAS mutations (codons 12 & 13) plus the BRAF V600E mutation in a single combination assay.
Cost-Effective Dual Testing
Highly cost-effective option for simultaneous KRAS-BRAF mutation profiling versus running two separate assays.
Oncology Therapy Guidance
Supports targeted therapy selection for colorectal, lung, and other KRAS/BRAF-driven cancers.
Reverse Hybridization
Based on reverse hybridization of biotinylated PCR products for sensitive parallel mutation detection.
For Research Use Only (RUO)
KRAS – BRAF StripAssay® is intended for research use only in the United States and is not FDA-cleared for diagnostic use.